Overview

This national symposium will focus on providing an in-depth and up-to-date review of the multidisciplinary management of colorectal cancers.

Learning Objectives

As a result of attending the course, the participant will be able to:

• Evaluate genomics-based treatment decision-making in colorectal cancer therapy.
• Evaluate total neoadjuvant therapy approaches to rectal cancer.
• Identify personalized approaches to metastatic colorectal cancer.

Target Audience

Oncologists, radiation oncologists, surgeons, and nurses with an interest in the management of patients with colorectal cancer should attend this course

Accreditation

Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.